ArticleslgStudy

biology

Gynecologic cancer disparities in the United States

Gynecologic cancer disparities in the United States is a biology topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Gynecologic cancer disparities in the United States rather than just read about it. In short: Gynecologic cancer disparities in the United States refer to differences in incidence, prevalence, and mortality from gynecologic cancers between population groups. The five main types of gynecologic cancer include cervical cancer, ovarian cancer, endometrial cancer, vaginal cancer, and vulvar cancer.

Gynecologic cancer disparities in the United States — main illustration
Gynecologic cancer disparities in the United States — illustration

Key takeaways

  • Gynecologic cancer disparities in the United States belongs to biology; place it in that map before memorising details.
  • Learn the definition first, then one example that makes the definition concrete.
  • Connect Gynecologic cancer disparities in the United States to a quantity you can measure, compute or draw — that is where exam questions come from.
  • Reproduce the core statement of Gynecologic cancer disparities in the United States from memory before moving on to harder problems.

Reference excerpt

Gynecologic cancer disparities in the United States refer to differences in incidence, prevalence, and mortality from gynecologic cancers between population groups. The five main types of gynecologic cancer include cervical cancer, ovarian cancer, endometrial cancer, vaginal cancer, and vulvar cancer. For patients with these and other gynecologic malignancies within the United States, disparities across the care continuum by socioeconomic status and racial/ethnic background have been previously identified and studied. The causes behind these disparities are multifaceted and a complex interplay of systemic differences in health as well as individual patient factors such as cultural, educational, and economic barriers.

Cervical cancer disparities Since the development of the Papanicolou smear or Pap smear in 1941, cervical cancer has been highly preventable. The implementation of Pap smear screening programs has resulted in a steady decline in incidence and mortality rates from cervical cancer since the mid-1970s. Even with this technology, the American Cancer Society still estimates that within the U.S., about 12,820 new cases of invasive cervical cancer will be diagnosed and 4,210 women will die of cervical cancer by the end of 2017. Despite an overall decline in incidence and mortality rates from cervical cancer for women across the United States, significant disparities have been documented amongst racial and ethnic minorities and socioeconomically marginalized populations. Within the United States, Hispanic women have the highest incidence of cervical cancer, and African Americans have the highest mortality.

Differences in screening practices Disparities amongst different minority groups have been attributed to different Pap smear screening practices. African Americans, American Indians, and non-white Hispanics have been found to be diagnosed at later stages than white women, which has been suggested as a potential contributing reason for their worse survival outcomes. One 2001 study in California found that Asian women were the least likely ethnic/racial group to have ever had a Pap test. This study also described varied trends existing within different Asian American subpopulations, identifying how Vietnamese women had the lowest screening rates (62.3%) and Filipino women had the highest screening rates (81.1%). It has also been discovered that foreign-born women in the U.S. have lower screening rates than those born in the U.S. Not only does there exist disparity in screening, but there also exists post-screening disparities in follow-up practices. Adherence to follow-up after abnormal Pap tests varies across minority groups. The National Breast and Cervical Cancer Early Detection Program, a national initiative focused on increasing access to cervical and breast cancer screening for underserved women followed more than 10,000 participants who had two or more abnormal Pap test results. They found 56% of these patients did not follow-up with a recommended cervical examination, and 27.7% of this group received no follow-up examination whatsoever. Within this study, African Americans had the highest rate of no follow-up. Across all racial/ethnic groups in the U.S., increased poverty and decreased education levels have been associated with higher mortality.

Differences in vaccination Human papilloma virus (HPV) is consistently present in almost all cervical cancer cases across the world and is the main etiologic factor in cervical cancer. The U.S. Advisory Committee on Immunization Practice advises that females receive the full series of three doses of quadrivalent HPV vaccine at 11–12 years of age. For females aged 13–26 years who have not been previously vaccinated, catch-up vaccination is recommended. Despite these national recommendations, the rate of HPV vaccination in the U.S. remains low. One study of 409 females aged 13–26 found that only 5% of participants had received one or more HPV vaccine dosages. Since parents have a critical role in deciding the vaccination of their young daughters, studies have found that parenting beliefs and attitudes are important to HPV vaccine practices of girls throughout the U.S.

Barriers to prevention

Cultural/personal barriers Non-adherence to screening and vaccination have been found to be influenced by cultural and personal beliefs and conditions. Interviews with females of ethnic minorities, specifically Chinese and Hispanics, have revealed that the implications of sexual activity that come with Pap smears impact females decisions to get screened. Some women revealed that they avoid screening to prevent others from thinking that they are sexually active or promiscuous due to embarrassment or concern about being discovered.

Socioeconomic and institutional barriers Receiving a recommendation by one's physician is strongly correlated with patients seeking out to be screened by a Pap smear. Across different racial and ethnic groups, having a regular doctor increases the likelihood of a patient undergoing regular Pap smearing. Additional barriers such as long wait times, lack of transportation, inability to take off work, lack of family support or available child care options can often impact patients' abilities to seek out and receive appropriate preventative measures and treatment.

Lack of knowledge and awareness Understanding cervical cancer and its link to human papillomavirus (HPV) is closely related to agreeing to undergo Pap smear screening or get vaccinated against HPV across population types. Cervical cancer patients who have never had a Pap test were more likely to have previously not been aware that they were capable of developing cervical cancer.

Differences in treatment There have been documented racial and ethnic disparities in clinical treatment for cervical cancer. Research has shown that African Americans are more likely than whites to go untreated. They are also less likely to receive clinical staging or be treated with surgery or combined therapy. Black women have a higher risk of dying from cervical cancer by 50%.

… excerpt ends here. Continue reading the full article.

Illustrations

Gynecologic cancer disparities in the United States: Cervix adenocarcinoma
Cervix adenocarcinoma

Worked examples

Example 1 — a first encounter with Gynecologic cancer disparities in the United States

Start with the simplest possible case. Write down what Gynecologic cancer disparities in the United States claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In biology, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Gynecologic cancer disparities in the United States before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Gynecologic cancer disparities in the United States ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Gynecologic cancer disparities in the United States

In research
Gynecologic cancer disparities in the United States appears in biology research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry
Engineering practice reuses Gynecologic cancer disparities in the United States in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom
Gynecologic cancer disparities in the United States is common in secondary-school and first-year university syllabi. It links to neighbouring topics Gynaecological cancer, Health equity, Social problems in medicine, so understanding it makes those chapters shorter.
In everyday life
Look for Gynecologic cancer disparities in the United States outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.
Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “Gynecologic cancer disparities in the United States” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Gynecologic cancer disparities in the United States in 20 minutes

  1. Read the reference excerpt below once, without taking notes.
  2. Close the page and write down what Gynecologic cancer disparities in the United States means in your own words.
  3. Compare your version with the excerpt and mark what you missed.
  4. Work through the three examples above with pen and paper.
  5. Explain Gynecologic cancer disparities in the United States out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Gynecologic cancer disparities in the United States in simple terms?

Gynecologic cancer disparities in the United States refer to differences in incidence, prevalence, and mortality from gynecologic cancers between population groups. The five main types of gynecologic cancer include cervical cancer, ovarian cancer, endometrial cancer, vaginal cancer, and vulvar canc…

Why does Gynecologic cancer disparities in the United States matter?

Because it connects several biology ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Gynecologic cancer disparities in the United States?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Gynecologic cancer disparities in the United States.

Tags

  • Gynaecological cancer
  • Health equity
  • Social problems in medicine
  • Women's health in the United States

Keep exploring